Stanley Druckenmiller’s portfolio: Duquesne Family Office 13F holdings
Quarterly SEC 13F-HR filingsCIK 0001536411Latest: Q2 2026
Q2 2013 filing in brief
In its Q2 2013 13F, filed August 14, 2013, Duquesne Family Office reported $674M across 17 US positions. The largest: Google Inc. (29.2%), CBS Corp (14.8%), DAL (10.7%), PG (6.5%), US Airways Group Inc. (5.8%).
Methodology
Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.
Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.
Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.
Holdings
Filed Aug 14, 2013
17 positions at June 30, 2013. No preceding quarter on file for comparison.
| Row | Ticker | Issuer | Status | ||||
|---|---|---|---|---|---|---|---|
| 1 | — | Google Inc. | $197M | 223.3K | 29.17% | — | — |
| 2 | — | CBS Corp | $100M | 2.0M | 14.83% | — | — |
| 3 | DAL | Delta Air Lines Inc. | $72M | 3.9M | 10.72% | — | — |
| 4 | PG | Procter & Gamble Co | $44M | 566.3K | 6.47% | — | — |
| 5 | — | US Airways Group Inc. | $39M | 2.4M | 5.76% | — | — |
| 6 | — | Charter Comm's Inc | $34M | 272.0K | 5.00% | — | — |
| 7 | WDAY | Workday Inc. | $32M | 505.5K | 4.81% | — | — |
| 8 | GILD | Gilead Sciences Inc. | $31M | 610.7K | 4.65% | — | — |
| 9 | BAC | Verizon Comm's Inc. | $24M | 473.0K | 3.53% | — | — |
| 10 | — | Cubist Pharms Inc. | $20M | 413.0K | 2.96% | — | — |
| 11 | BIIB | Biogen Idec Inc. | $20M | 91.5K | 2.92% | — | — |
| 12 | — | LyondellBasell Ind's NV | $14M | 218.0K | 2.14% | — | — |
| 13 | JNJ | Johnson & Johnson | $11M | 129.0K | 1.64% | — | — |
| 14 | XLF | Select Sector SPDR TR | $11M | 544.7K | 1.58% | — | — |
| 15 | BA | Boeing Co | $10M | 99.2K | 1.51% | — | — |
| 16 | BSX | Boston Scientific Corp | $9M | 1.0M | 1.38% | — | — |
| 17 | XLK | Select Sector SPDR TR | $6M | 204.5K | 0.93% | — | — |
Every quarter on file (53)
From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.